Neurology and Neuroscience

Amer Alghaben is currently the Managing Director of GxP Compliance and Training Partners (GCTP), which he founded, helping pharmaceutical companies & academic institutions worldwide to achieve compliance with GCP, GVP, GCLP, GDP and GLP. Amer, a Clinical pharmacologist by education, has over 28 years’ experience in the pharmaceutical industry. He enjoys imparting his experiences, as an invited speaker at over 120 international congresses and as writer, published 2 reference books, The Pharmaceutical Medicine Dictionary and The Dictionary of Pharmacovigilance and other publications. Earlier in his career, he was Assistant Editor for 11 medical journals and was the 1st invited Course Director for The Pharmacovigilance Auditing Course at the RQA. His other previous positions included: Vice President GxP Quality Assurance, Compliance & Training at Karyopharm Therapeutics Inc. Boston, USA, Global Director, Head of Quality Assurance at Merck Serono, Geneva, Switzerland, Global Head of GxP Quality Assurance at Arpida Ag., Switzerland, Senior International Clinical Quality Assurance Audit Manager at Novartis Headquarters, Basel, Switzerland and he was the first Pharmacovigilance Compliance Officer of the MHRA in the UK.

Clinical pharmacologist

Dr. Asif Taqi received his medical degree from Dow Medical College in Karachi. He completed his Neurology residency at the University of Tennessee and a fellowship in Critical care, Vascular Neurology and Endovascular Interventional Neuroradiology at Medical College of Wisconsin. He is triple board certified in Neurology, Vascular neurology and Critical Care Neurology. He currently leads the comprehensive stroke and neuroendovascular programs at Los Robles Hospital and Medical Center, West Hills Hospital and Medical Center, and Northridge Hospital. Dr. Taqi is a senior member of Society of NeuroInterventional Surgery (SNIS), Society of Vascular and Intervention Neurology (SVIN) and a fellow of American Heart Association (FAHA).

Neuroradiology